Singapore got Pfizer vaccine quicker because Temasek Holdings had a stake in BioNTech, says KJ


KUALA LUMPUR: Among the reasons why Singapore was ahead of Malaysia in procuring Covid-19 vaccines was because Temasek Holdings and other investors had invested US$250mil (RM1.06bil) into German biotech company BioNTech, says Khairy Jamaluddin.

The Science, Technology and Innovation Minister said it was likely that Singapore was prioritised by BioNTech, which developed the Pfizer-BioNTech Covid-19 vaccine in a joint venture with Pfizer, because Temasek Holdings has a stake in the company.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Penang tunnel project studies incomplete due to port expansion plans
US court sentences M'sian 'Fat Leonard' sentenced to 15 years for corruption
Morning thunderstorms forecast in some states, including Selangor and KL
INTERACTIVE: Malaysia’s treasure trove of metals and minerals
Nearly 32,000 motorbikes inspected in four days
AWS IS BUILDING LOCAL, AND GOING GLOBAL
Committed to a greener future
Third BSI pedestrian route proposal stalls
Police op reduces motorcycle accidents by 10.1%
MACC officer charged with misusing seized funds

Others Also Read